Felix González-López de Turiso

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Radical Cyclization Approach to Spirocyclohexadienones

Felix González-López de Turiso, Dennis P. Curran · Organic Letters · 2004 · 116 citations

Natural Sciences, Medicinal Chemistry, Pharmacology +10

Discovery and in Vivo Evaluation of (<i>S</i>)-<i>N</i>-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9<i>H</i>-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease

Timothy D. Cushing, Xiaolin Hao, Youngsook Shin et al. · Journal of Medicinal Chemistry · 2014 · 86 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors

Felix González-López de Turiso, Daqing Sun, Yosup Rew et al. · Journal of Medicinal Chemistry · 2013 · 84 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15